
Oncology & Hematology




February 10, 2025
BOREAS Trial: Navtemadlin Demonstrates Clinical Benefit in JAK Inhibitor–Refractory Myelofibrosis
The ASCO Post

February 10, 2025
Novel Menin Inhibitors Show Safety and Activity in Several Clinical Trials
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.


February 10, 2025
Pertuzumab Retreatment in HER2-Positive Locally Advanced/Metastatic Breast Cancer
The ASCO Post

February 07, 2025
Non-DRE Urine Test May Help Avoid Biopsies for Detection of Prostate Cancer
Conexiant

Advertisement
Recommendations
Advertisement